Bis(μ-2-fluoro­benzoato-1:2κ(2) O:O′)(2-fluoro­benzoato-1κ(2) O,O′)(2-fluoro­benzoato-2κO)dinicotinamide-1κN (1),2κN (1)-dizinc(II)–2-fluoro­benzoic acid (1/1)

The asymmetric unit of the title compound, [Zn(2)(C(7)H(4)FO(2))(4)(C(6)H(6)N(2)O)(2)]·C(7)H(5)FO(2), consists of a binuclear Zn(II) complex bridged by two carboxyl groups of 2-fluoro­benzoate (FB) anions and a 2-fluoro­benzoic acid mol­ecule. The two bridging FB anions, one chelating FB anion and one nicotinamide (NA) ligand coordinate to one Zn cation with a distorted square-pyramidal geometry, while the two bridging FB anions, one monodentate FB anion and one NA ligand coordinate to the other Zn cation with a distorted tetra­hedral geometry. Within the binuclear mol­ecule, the pyridine rings are oriented at a dihedral angle of 19.41 (14)°. In the crystal structure, the uncoordinated 2-fluorobenzoic acid mol­ecules are linked by O—H⋯O hydrogen bonding, forming centrosymmetric supra­molecular dimers. Inter­molecular N—H⋯O hydrogen bonds link the complex mol­ecules into a three-dimensional network. The π–π contacts between nearly parallel pyridine and benzene rings [dihedral angles of 19.41 (14) and 12.72 (16)°, respectively, centroid–centroid distances = 3.701 (2) and 3.857 (3) Å] may further stabilize the crystal structure. The fluorine atoms in two FB ligands are disordered over two positions, with occupancy ratios of 0.70:0.30.